GUFIC BIOSCIENCES LTD. Financial Ratios
GUFICBIO · Healthcare · Current price ₹381.9
P/E ratio
54.8x
P/B ratio
5.8x
ROE
11.6%
ROCE
13.0%
Debt / Equity
0.61
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 54.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 5.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 11.6% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 13.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.61 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with GUFIC BIOSCIENCES LTD.'s latest numbers.
GUFIC BIOSCIENCES LTD. profitability
GUFIC BIOSCIENCES LTD. generates a return on equity of 11.6% and a return on capital employed of 13.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.61 and a P/E of 54.8x, GUFIC BIOSCIENCES LTD. is moderately leveraged. Our overall business-quality score for the company is 2.8 / 10.
Understand the ratios
More on GUFIC BIOSCIENCES LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.